MOLECULIN BIOTECH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.15 USD | +1.78% |
|
+19.54% | -60.00% |
| 05-01 | Moleculin Biotech, Inc. Announces Formation of Annamycin Scientific Advisory Board and Inaugural Appointment of Martin Tallman | CI |
| 04-25 | Transcript : Moleculin Biotech, Inc. - Special Call |
Chart calendar Moleculin Biotech, Inc.
4b986c0357884840777f4e74567341c8.P6EFkllCHQCSkCgEiLmQCPtu0WCQ6Jd12wokt8Xx8-8.ZZdJ_gAUSXPk2x1pse_HMZ8s4lCp2Pot70J8h4yamLZ5wnTLK3psc9fKWw~94982c6e3d07ce2a3448e1b6cab23d73
Upcoming events on Moleculin Biotech, Inc.
Past events on Moleculin Biotech, Inc.
| 07/04/2024 | American Association for Cancer Research Meeting |
| 04/04/2024 21:10 | MedInvest Biotech & Pharma Investor Conference |
| 25/03/2024 12:30 | Q4 2023 Earnings Call |
| 22/03/2024 20:05 | Q4 2023 Earnings Release |
| 18/03/2024 16:00 | Roth Conference |
| 13/11/2023 13:30 | Q3 2023 Earnings Call |
| 13/11/2023 13:00 | Q3 2023 Earnings Release |
| 01/11/2023 | CTOS Meeting |
| 24/10/2023 17:00 | Virtual Investor Ask the CEO Conference |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 11/08/2023 13:30 | Q2 2023 Earnings Call |
| 11/08/2023 11:45 | Q2 2023 Earnings Release |
| 12/07/2023 20:00 | Virtual Investor Summer Spotlight Series |
| 21/06/2023 18:30 | Maxim Group Virtual Healthcare Conference |
| 15/06/2023 15:30 | Annual General Meeting |
| 11/05/2023 13:30 | Q1 2023 Earnings Call |
| 11/05/2023 12:05 | Q1 2023 Earnings Release |
| 18/04/2023 18:30 | American Association for Cancer Research Meeting - Abstract-4947 / 25 |
| 23/03/2023 12:30 | Q4 2022 Earnings Call |
| 23/03/2023 11:10 | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -29,5 -23,7 -24.49% | -28,0 |
|
EBIT Million USD | Released Forecast Spread | -17,5 -17,6 0.69% | -19,7 -22,3 11.43% | -23,0 -24,1 4.65% | -30,6 -32,5 5.6% | -29,6 -27,1 -9.43% | -30,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,4 -14,7 8.87% | -17,4 -20,9 16.76% | -15,9 -18,6 14.74% | -29,0 -31,4 7.55% | -29,8 -25,6 -16.08% | -30,2 |
|
Net income Million USD | Released Forecast Spread | -13,2 -14,4 8.42% | -17,4 -20,8 16.43% | -15,9 -19,0 16.47% | -29,0 -31,0 6.36% | -29,8 -25,6 -16.08% | -30,2 |
|
EPS USD | Released Forecast Spread | -28,8 -31,8 9.43% | -26,4 -31,9 17.37% | -8,85 -10,6 16.9% | -15,1 -16,2 6.77% | -15,1 -13,0 -15.92% | -11,5 |
| Announcement Date | 19/03/20 | 24/03/21 | 24/03/22 | 22/03/23 | 22/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -5,21 -6,31 17.54% | -7,07 -6,14 -15.19% | -7,43 -7,36 -0.94% | -9,08 -8,03 -13.11% | -7,05 -8,89 20.71% | -8,35 -8,26 -1.16% | -6,41 -8,36 23.34% | -5,95 -7,02 15.33% | -8,92 -6,37 -40.03% | -7,55 | -6,83 | -7,99 | -8,20 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,83 -5,57 49.3% | -6,87 -5,81 -18.25% | -6,78 -7,37 8.08% | -8,61 -8,17 -5.34% | -6,77 -9,14 25.92% | -7,92 -8,38 5.57% | -5,98 -8,59 30.43% | -5,61 -6,96 19.35% | -10,3 -6,15 -67.09% | -7,40 | -6,70 | -7,88 | -8,12 |
|
Net income Million USD | Released Forecast Spread | -2,83 -5,95 52.5% | -6,87 -6,10 -12.51% | -6,78 -7,32 7.35% | -8,61 -8,02 -7.42% | -6,77 -8,74 22.56% | -7,92 -8,10 2.3% | -5,98 -8,18 26.91% | -5,61 -6,94 19.14% | -10,3 -6,15 -67.09% | -7,40 | -6,70 | -7,88 | -8,12 |
|
EPS USD | Released Forecast Spread | -1,35 -3,15 57.14% | -3,60 -3,15 -14.29% | -3,60 -3,80 5.26% | -4,50 -4,15 -8.43% | -3,45 -4,55 24.18% | -4,20 -4,25 1.18% | -3,00 -4,10 26.83% | -2,85 -3,35 14.93% | -14,4 -3,05 -372.46% | -3,53 | -3,22 | -3,16 | -2,26 |
| Announcement Date | 24/03/22 | 11/05/22 | 12/08/22 | 10/11/22 | 22/03/23 | 10/05/23 | 10/08/23 | 13/11/23 | 22/03/24 | - | - | - | - |
More events
Past sector events for Moleculin Biotech, Inc.
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BICYCLE THERAPEUTICS PLC: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MBRX Stock
- Calendar Moleculin Biotech, Inc.
